Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD
SHANGHAI, Jan. 6, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that China’s National Medical Products Administration…
